Two new medications, called lecanemab and donanemab, have shown success in clinical trials in slowing down Alzheimer’s disease. These are known as disease-modifying treatments and have been licensed ...

Dexamphetamine—a restricted stimulant drug used to treat narcolepsy and Attention Deficient Hyperactivity Disorder ...

This was highlighted by Dr Sermed Mezher in a recent reel posted on Instagram, “People with KLS experience recurring episodes where they sleep excessively, sometimes up to 20 hours a day, for weeks at ...